Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Renal Cell × olaparib × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 23 Triple Negative Breast Neoplasms 16 Prostatic Neoplasms 15 Fallopian Tube Neoplasms 11 Neoplasms 8 Pancreatic Neoplasms 6 Glioma 6 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Fanconi Anemia, Complementation Group D1 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Breast Cancer 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Osteosarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lung Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Uveal Melanoma 2

Interventions

Sunitinib 52 Nivolumab 45 Sorafenib 35 Bevacizumab 31 Axitinib 31 pembrolizumab 29 cabozantinib 28 Everolimus 25 pazopanib 23 aldesleukin 23 Ipilimumab 21 Interleukin-2 17 Magnetic Resonance Spectroscopy 15 Interferon-alpha 15 Gemcitabine 15 lenvatinib 13 Specimen Handling 13 Radiosurgery 12 Interferon alpha-2 12 Cyclophosphamide 12 fludarabine phosphate 11 Erlotinib Hydrochloride 8 temsirolimus 7 atezolizumab 7 Introns 7 Capecitabine 7 durvalumab 6 avelumab 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2025-03-13

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡